CL

Business profile & competitive position

Colgate-Palmolive Company is classified in the Consumer Defensive sector, specifically the Household & Personal Products industry. The company operates through two main segments: Oral, Personal and Home Care, which covers toothpaste, toothbrushes, soaps, deodorants, skin health products, household cleaners and fabric conditioners; and Hill's Pet Nutrition, which produces specialty dog and cat foods. Its products reach more than 200 countries and territories through retailers, wholesalers, eCommerce platforms, veterinarians and certain direct-to-consumer channels.

The 2025 segment revenue breakdown shows Oral Care at 44% of worldwide net sales, Personal Care at 17%, Home Care at 16% and Pet Nutrition at 23%. That mix means the company is not solely a toothpaste business: pet nutrition is a meaningful, separate demand pool. In terms of distribution concentration, Walmart and its affiliates accounted for approximately 11% of 2025 net sales, and no other single customer exceeded 10%.

The financial markers for competitive strength are mixed. Net margin of 9.7% is respectable for a packaged-goods business, and return on equity of 631.1% is extraordinarily high. In practice, an ROE that large usually signals a low equity base supported by leverage, share buybacks or debt rather than pure operating returns on assets. Colgate's beta of 0.32 is extremely low, reflecting the non-discretionary nature of its core products and relatively stable demand. Taken together, the figures paint a picture of a mature, globally diversified consumer staples company with durable brand reach and a heavily optimized capital structure, rather than a high-growth disruptor.

Financial posture

As of the current snapshot, Colgate-Palmolive carries a market capitalization of $71.0 billion and trades at a P/E ratio of 34.9. That multiple sits at a level investors typically associate with high-quality defensive names where consistency is priced in. The net margin of 9.7% shows the company converts sales into profit, while the 631.1% ROE underscores how aggressively the balance sheet has been leveraged or how much equity has been returned to shareholders over time.

Beta of 0.32 implies the stock has historically moved less than one-third as much as the broader market, consistent with the Consumer Defensive classification. The current price is $88.77, below the 50-day EMA of $91.00, and the RSI reading of 40.2 is neither overbought nor deeply oversold. The combination of a premium valuation multiple, a low beta and a price sitting under a near-term moving average is simply data points investors can use when forming their own view; it does not, by itself, signal an opportunity or a risk.

Strategic priorities & outlook

Colgate-Palmolive's most recent SEC 10-K filing outlines a set of priorities centered on compounding shareholder value through steady execution. The company aims to drive organic sales growth and deliver consistent, compounded earnings-per-share growth. Operational efficiency is a parallel goal, with management targeting free-cash-flow expansion and efficient use of the balance sheet.

On the commercial side, the strategy leans on global brand reach, science-based innovation, an agile supply chain and what it describes as best-in-class omni-channel demand generation. It is also investing in data, analytics and artificial intelligence capabilities while trying to evolve what it calls a high-impact, inclusive culture. Operationally, the company employed approximately 33,600 people across more than 100 countries as of December 31, 2025, with over 84% of that workforce located outside the United States. That geographic footprint is consistent with a business that sources, manufactures and sells on a global scale.

Macro & geopolitical exposure

Because Colgate-Palmolive sits in Consumer Defensive / Household & Personal Products, the business is exposed to a specific set of macro and geopolitical forces. Demand for toothpaste, soap, pet food and household cleaners tends to be relatively stable, but the company's global operating model introduces currency risk. With more than 84% of employees outside the U.S. and sales across more than 200 territories, exchange-rate swings can materially affect translated revenue and costs.

The sector is also sensitive to commodity and input-cost inflation: plastics, chemicals, surfactants, fragrances, packaging materials and pet-food ingredients all move with energy and agricultural markets. Freight, tariffs and trade policy matter for a company that manufactures and ships worldwide. Regulatory exposure includes product-safety rules, environmental and packaging regulations, and, for Hill's Pet Nutrition, veterinary and animal-feed oversight. Interest-rate levels can affect debt-service costs given the leveraged balance sheet implied by the 631.1% ROE, and consumer trade-down behavior during economic stress can pressure pricing power even in staple categories.

Recent developments

The recent news flow around CL has carried a defensive, income-oriented tone. On September 6, 2026, a Fool.com headline named Colgate-Palmolive among three dividend stocks to consider buying in September, citing the S&P 500's historically low yield. On September 4, 2026, 247wallst.com included the company in a list of three all-weather dividend stocks that keep increasing payouts. That same day, defenseworld.net reported that Baypointe Partners LLC had sold shares of Colgate-Palmolive, a reminder that institutional flows around the stock are not uniformly positive. On September 3, 2026, Zacks.com published an article titled "Here's Why Colgate-Palmolive (CL) is a Strong Growth Stock," adding a growth-oriented narrative to the dividend-focused coverage.

Collectively, the recent headlines show the stock being discussed as both a quality dividend name and a growth candidate, while a disclosed institutional sale adds a note of caution about ownership trends.

Earnings behavior & post-earnings drift

Colgate-Palmolive has a strong recent earnings record. Over the last eight reported quarters, the company beat estimates in all eight, for a 100% beat rate, with an average earnings surprise of 3.3%. The average five-day price move in the trading sessions after earnings across those eight quarters was 2.32%, classified as an "up" drift.

The last four quarters illustrate the nuance behind that average. On July 31, 2026, CL reported EPS of $0.99 against a $0.947 estimate, a 4.5% surprise; the stock fell 1.56% the next day but rose 2.16% over the following five days. On May 1, 2026, EPS of $0.97 beat the $0.943 estimate by 2.9%; the next-day move was -2.17%, with only a 0.33% gain over the next five days. On January 30, 2026, EPS of $0.95 beat the $0.912 estimate by 4.2%, producing a 1.77% next-day gain and a 4.56% five-day gain. On October 31, 2025, EPS of $0.91 beat the $0.889 estimate by 2.4%, yet the stock fell 2.69% the next day before recovering 2.22% over the following five days.

The pattern is worth noting: the market's real expectation may already be embedded in the price, because in three of the last four reports the stock sold off immediately despite beats. The average positive five-day drift suggests that, at least historically, any initial disappointment has tended to fade as investors digest the results. The next scheduled report is October 30, 2026, before the market open, with a consensus EPS estimate of $0.92.

For a deeper dive into how institutional analysts and quantitative models currently view Colgate-Palmolive, including the full institutional verdict on valuation, sentiment and earnings positioning, readers should consult the complete platform research page for CL.